Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Margaret A. Crawford
Observed names:
MARGARET CRAWFORD,
Margaret Crawford
Institution:
Dexcom (United States)
Observed institution:
Dexcom (United States)
OpenAlex ID:
A5082214137
669-P: Lower Peak Glucose and Increased Time in Range (TIR) in a CGM-Wearing T2D Population Not Taking Fast-Acting Insulin Shows Value of Real Time–CGM (rtCGM) as a Behavior Change Tool
2022
·
MARGARET A. CRAWFORD
, DANIEL R. CHERÑAVVSKY
, et al.
·
Diabetes
·
11
1852-LB: “I realized that I could control my health with better eating habits and exercise”—Significant Improvements in Psychosocial Health and Lifestyle in People with Prediabetes Using Dexcom rtCGM
2024
·
MARGARET A. CRAWFORD
, CHRISTIAN HICKS
, et al.
·
Diabetes
·
2
1927-LB: Real-World Dexcom CGM Use in T2D NIT—Reduced Diabetes Distress and Improved Self-Care Behaviors
2025
·
MARGARET A. CRAWFORD
, CHRISTIAN HICKS
, et al.
·
Diabetes
·
1
1133-P: Value of Dexcom CGM for Therapy Optimization and Glycemic Outcomes in Post-Hospital Discharge Type 2 Diabetes Patients—An Exploratory Study
2024
·
MARGARET A. CRAWFORD
, CHRISTIAN HICKS
, et al.
·
Diabetes
·
1
63-LB: Real-Time Continuous Glucose Monitoring (rtCGM) Is Associated with Improved Clinical and Psychosocial Health in People with Type 2 Diabetes on Basal Insulin (T2D-BI)
2023
·
MARGARET A. CRAWFORD
, CHRISTIAN HICKS
, et al.
·
Diabetes
·
1
2795-LB: Increased Confidence and Behavioral Adaptation: Exploring Dexcom CGM Use during Ramadan in People with Diabetes
2026
·
MARGARET CRAWFORD
, CHRISTIAN HICKS
, et al.
·
Diabetes
1914-P: From Data to Action: Early Real-World Evidence on Behavioral Change and Feature Engagement with Stelo
2026
·
MARGARET CRAWFORD
, NIKHITA GOPISETTY
, et al.
·
Diabetes
1556-P: Beyond Glucose: Understanding the Psychosocial and Behavioral Value of Dexcom CGM among Young Adults with Diabetes
2026
·
MARGARET CRAWFORD
, CHRISTIAN HICKS
, et al.
·
Diabetes
Discharge Remote Monitoring Systems for Glycemic Management After Hospital Discharge
2026
·
Nirali Shah
, Camilla Levister
, et al.
·
Chronic Diseases and Translational Medicine
2020-LB: Early Experiences with Stelo—Real-World Behavioral and Glycemic Outcomes in Users with Type 2 Diabetes, Prediabetes, or No Diabetes
2025
·
MARGARET A. CRAWFORD
, ANGELO MONROY
, et al.
·
Diabetes
1242-P: Dexcom CGM Use and Satisfaction in a Diverse Gestational Diabetes Cohort—Insights Into Glycemic Management and Patient Experiences
2025
·
MARGARET A. CRAWFORD
, ANGELO M. SPANGENBERG
, et al.
·
Diabetes
984-P: Exploring the Impact of Dexcom CGM and Levels Metabolic Health App’s Meal Logging Feature on Glycemic Outcomes and Behaviors across BMI Categories in a Real-World Cohort without Diabetes
2025
·
MARGARET A. CRAWFORD
, CHRISTIAN HICKS
, et al.
·
Diabetes
993-P: Exploring CGM Adherence and Glycemic Metrics in People with Diabetes—Real-World Data from Dexcom Users
2024
·
CHRISTIAN HICKS
, MARGARET A. CRAWFORD
, et al.
·
Diabetes
328-OR: Effect of Unblinded vs. Blinded Dexcom G6 CGM Wear in Outpatients with Type 2 Diabetes—Real-World Data
2023
·
CHRISTIAN HICKS
, TERESA ZHOU
, et al.
·
Diabetes
677-P: Exploring the Impact of CGM on Perceived Control of Non-Intensive Insulin Treated Type 2 Diabetes—“I liked keeping my line with as few spikes as possible”
2023
·
MARGARET A. CRAWFORD
, CHRISTIAN HICKS
, et al.
·
Diabetes
668-P: Increased Step Count but No Improvements in Glucose Control: Using CGM as Visualization Tool in Adults with T2D
2022
·
MARGARET A. CRAWFORD
, DANIEL R. CHERÑAVVSKY
, et al.
·
Diabetes
Show more works
View as search
Works count:
16
Citation count:
16
H-index:
2
I10-index:
1
Year
Topic
Type